Xeris Pharmaceuticals | XERS - 应收帐款人



金融业
股票价格
USD
资产
USD 411.91M
现金及等价物
USD 121.75M
销售成本
USD 10.57M
流动资产
USD 274.76M
流动负债
USD 189.57M
债务
USD 258.55M
EBIT
USD 9.12M
EBITDA
USD 12.33M
员工
377
EPS每股收益
USD 0.01
股本和储备
USD -9.73M
销售毛利
USD 72.55M
债务利息支出
USD 6.88M
利息收入
USD 1.2M
贷款资金
USD 188.81M
市值
USD 1.24B
净收入
USD 2.23M
营业费用
USD 75.21M
营业利润
USD 7.92M
普通股股本
USD 172.56M
PE价格收益
76.05
税前利润
USD 2.23M
销售收入
USD 83.13M
销售和管理费用
USD 53.14M
股票
USD 80.93M
贸易债权人
USD 9.34M
应收帐款人
USD 56.3M


应收帐款人 更改 日
Celltrion KRW 2.01T 39.71B 2026-03
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 1.23M 1.18M 2026-03
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
Eli Lilly USD 23.48B 2.3B 2026-06
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Organigram Holdings CAD 53.39M 3.45M 2026-03
Ovoca Bio EUR 53K 14K 2025-12
Pacira USD 132.42M 6.78M 2026-06
Perrigo USD 697.1M 84.3M 2026-03
Pharma Mar EUR 58.06M 6.87M 2026-06
Qiagen NV USD 398.35M 1.73M 2026-06
Sartorius EUR 381.2M 14.6M 2026-06
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Supernus Pharmaceuticals USD 211.66M 29.47M 2026-06
Tilray USD 109.07M 2M 2025-09
Zealand Pharma A/S 259M 81M 2026-03
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03